Liver Enzymes and Incident Diabetes

OBJECTIVE—We sought to examine the association between plasma concentrations of liver enzymes γ-glutamyltransferase (GGT) and alanine transaminase (ALT) and incident diabetes, prospectively. RESEARCH DESIGN AND METHODS—We conducted a case-cohort analysis of data from participants mainly aged 35–65 years in the European Prospective Investigation into Cancer and Nutrition–Potsdam Study. The analytic sample included 787 participants with incident diabetes and 2,224 participants without diabetes. RESULTS—Concentrations of GGT and ALT were significantly associated with incident diabetes after extensive adjustment. Compared with participants in the lowest quintile of GGT, the adjusted hazard ratios for increasing quintiles were 1.13 (95% CI 0.66–1.93), 1.67 (1.01–2.77), 2.77 (1.71–4.49), and 2.67 (1.63–4.37), respectively (P for linear trend <0.001). Compared with participants in the lowest quintile of ALT, the adjusted hazard ratios for incident diabetes were 0.93 (0.56–1.53) for quintile 2, 1.28 (0.83–1.96) for quintile 3, 1.35 (0.88–2.07) for quintile 4, and 1.93 (1.27–2.92) for quintile 5 (P for linear trend = 0.002). The magnitude of the associations were higher among men than women for GGT (P = 0.004) but did not differ significantly between men and women for ALT (P = 0.307). CONCLUSIONS—Concentrations of GGT and ALT were significant predictors of incident diabetes in this study, even at concentrations still considered to be within the normal range.

[1]  I. Kamae,et al.  The logistic regression and ROC analysis of group-based screening for predicting diabetes incidence in four years. , 2006, The Kobe journal of medical sciences.

[2]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[3]  D. Jacobs,et al.  γ-Glutamyltransferase, Obesity, and the Risk of Type 2 Diabetes: Observational Cohort Study among 20,158 Middle-Aged Men and Women , 2004 .

[4]  K. Suzuki,et al.  Serum γ‐glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle‐aged Japanese men , 2003, Journal of internal medicine.

[5]  H. Boeing,et al.  Recruitment Procedures of EPIC-Germany , 1999, Annals of Nutrition and Metabolism.

[6]  H. Boeing,et al.  EPIC-Germany – A Source for Studies into Diet and Risk of Chronic Diseases , 1999, Annals of Nutrition and Metabolism.

[7]  P. Macfarlane,et al.  Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. , 2004, Diabetes.

[8]  S. Wannamethee,et al.  Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. , 1998, Diabetes care.

[9]  S. Haffner,et al.  Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. , 2005, Diabetes care.

[10]  C. Meisinger,et al.  Serum γ‐glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population , 2005, Journal of internal medicine.

[11]  D. Jacobs,et al.  gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  A. Zanella,et al.  Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.

[13]  P. Whincup,et al.  Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. , 2005, Diabetes care.

[14]  M. Charles,et al.  Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort , 2006, Diabetologia.

[15]  H. Boeing,et al.  Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. , 1999, Annals of nutrition & metabolism.

[16]  D. Befroy,et al.  Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.

[17]  A. Ceriello,et al.  Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[18]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[19]  P. Björntorp,et al.  Risk factors for Type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913 , 1988, Diabetologia.

[20]  C. Bogardus,et al.  High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[21]  S. Wannamethee,et al.  Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDM , 1998, Diabetes Care.

[22]  K. Tatara,et al.  Serum γ-Glutamyltransferase and Risk of Metabolic Syndrome and Type 2 Diabetes in Middle-Aged Japanese Men , 2004 .

[23]  C. Lewis,et al.  γ-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2003 .

[24]  D. Jacobs,et al.  Gamma-glutamyltransferase and diabetes—a 4 year follow-up study , 2003, Diabetologia.

[25]  G. Nijpels,et al.  No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study. , 2005, Diabetes care.

[26]  D. Jacobs,et al.  ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress? , 2004, Free radical research.

[27]  B. Zinman,et al.  Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. , 2004, Diabetes.

[28]  Lee Goldman,et al.  Cecil Textbook of Medicine , 1985 .

[29]  I. de Sio,et al.  Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.